The effect of budesonide on the cytokine pattern in patients with perennial allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 91, Issue 5, 2003, Pages 467-471

  Ciprandi, Giorgio ^a   Tosca, Maria Angela ^a   Cirillo, Ignazio ^b   Vizzaccaro, Andrea ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b Ospedale Marina Militare   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PLACEBO;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EVALUATION; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOMODULATION; LAVAGE; LIQUID; MALE; MEASUREMENT; NASAL PRURITUS; NOSE; NOSE MUCUS; NOSE OBSTRUCTION; PARAMETER; PATIENT; PERENNIAL RHINITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SCORING SYSTEM; SNEEZING; SYMPTOM; TREATMENT OUTCOME;

EID: 0345256538     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61515-3     Document Type: Article

References (23)

1. Howarth PH, Wilson S, Lau L, et al. The nasal mast cell and rhinitis. Clin Exp Allergy. 1991;21(Suppl):3-15.
2. Gomez E, Corrado OJ, Baldwin DL, Swanston AR, Davies RJ. Direct in vivo evidence for mast cell degranulation during allergen-induced reactions in man. J Allergy Clin Immunol. 1986;78:637-645.
3. Christodoupoulos P, Cameron L, Durham S, Hamid Q. Molecular pathology of allergic disease II: upper airway disease. J Allergy Clin Immunol. 2000;105:211-223.
4. Nielsen LP, Mygind N, Dahl R. Intranasal corticosteroids for allergic rhinitis: superior relief? Drugs. 2001;61:1563-1579.
5. Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties and therapeutic efficacy in asthma and rhinitis. Drugs. 1992;3:375-407.
6. Meltzer EO. Clinical and anti-inflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol. 1998;81: 128-134.
7. Xaubet A, Mullol J, Roca-Ferrer J, et al. Effect of budesonide and nedocromil sodium on IL6 and IL8 release from human nasal mucosa and polyp epithelial cells. Respir Med. 2001;95: 408-414.
8. Greiff L, Petersen H, Mattsson E, et al. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment. Clin Exp Allergy. 2001;31: 1321-1327.
9. Benson M, Strannegard IL, Strannegard O, et al. Topical steroid treatment of allergic rhinitis decreases nasal fluid Th2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-γ, IL1-β, TNF-α, or neutrophils. J Allergy Clin Immunol. 2000;106:307-312.
10. Benson M, Strannegard IL, Wennergren G, et al. IL5 and IL8 in relation to eosinophils and neutrophils in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol. 1999;10:178-185.
11. Kita H, Jorgensen RK, Reed CE, et al. Mechanism of topical glucocorticoid treatment of hay fever: IL5 and eosinophil activation during natural allergen exposure are suppressed, but IL4, IL6, and IgE antibody production are unaffected. J Allergy Clin Immunol. 2002;106:521-529.
12. Linden M, Svennson C, Andersson E, et al. Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of GM-CSF and IL5. Am J Crit Care Med. 2000; 162:1705-1708.
13. Dykewicz MS, Fineman S. Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol. 1998;81:463-468.
14. Ciprandi G, Cosentino C, Milanese M, et al. Fexofenadine treatment reduces nasal congestion in allergic rhinitis. Allergy. 2001;56:1068-1070.
15. Società Italiana di Allergologia e Immunologia Clinica. Memorandum della Diagnostica delle Allergopatie. Fed Med. 1987; 40:861-874.
16. Riccio AM, Tosca MA, Cosentino C, et al. Cytokine pattern in allergic and non-allergic chronic rhinosinusitis in asthmatic children. Clin Exp Allergy. 2002;32:422-426.
17. Sulakvelidze I, Conway H, Evans S, et al. Clinical and nasal irrigation fluid findings in perennial allergic rhinitis. Am J Rhinol. 1997;11:435-441.
18. Bradding P, Feather IH, Wilson S, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects: the mast cell as a source of IL4, IL5, and IL6 in human allergic mucosal inflammation. J Immunol. 1993;151: 3853-3865.
19. Kon OM, Kay AB. T cells and chronic asthma. Int Arch Allergy Immunol. 1999;118:133-135.
20. Hirano T. Interleukin 6 and its receptors: ten years later. Int Rev Immunol. 1998;16:249-271.
21. Howarth PH. A comparison of the anti-inflammatory properties of intranasal corticosteroids and antihistamines in allergic rhinitis. Allergy. 2000;62:6-11.
22. Trangsrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy. 2002;22: 1458-1467.
23. Bousquet J. Requirements for medication commonly used in the treatment of allergic rhinitis. Allergy. 2003;58:192-197.